Low-dose methotrexate as rescue therapy in patients with hidradenitis suppurativa and pyoderma gangrenosum developing human antichimeric antibodies to infliximab: A retrospective chart review
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference4 articles.
1. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease;Afif;Am J Gastroenterol,2010
2. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease;Baert;N Engl J Med,2003
3. Infliximab for the treatment of hidradenitis suppurativa;Fernández-Vozmediano;Dermatology,2007
4. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial;Brooklyn;Gut,2006
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17
2. Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm;Expert Review of Clinical Immunology;2023-12-22
3. Treatment of Pyoderma Gangrenosum;Dermatologic Clinics;2023-12
4. Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments;American Journal of Clinical Dermatology;2022-05-24
5. Recommandations dans l’hidradénite suppurée;Annales de Dermatologie et de Vénéréologie - FMC;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3